中医药治疗腹膜透析相关性腹膜纤维化实验研究进展

    Experimental research advances of treating peritoneal dialysis-related peritoneal fibrosis with traditionalChinese medicine

    • 摘要: 腹膜纤维化是腹膜透析患者腹膜病变最常见的一种类型,主要以细胞外基质蛋白的异常产生、腹膜间质层结缔组织增厚、腹膜间皮细胞损伤以及新生血管形成为特点,目前缺乏有效的防治措施。中医药防治腹膜纤维化具有独特的优势,临床疗效较好,在实验研究方面也取得了一定的进展。本文将从腹膜纤维化动物模型造模方法、单味中药、中药复方及针灸在腹膜纤维化治疗中的实验研究进展做一综述,以期为临床上运用中医药防治腹膜透析相关性腹膜纤维化提供基础理论指导。

       

      Abstract: Peritoneal fibrosis is the most common type of peritoneal lesions in peritoneal dialysis (PD)patients. It is characterized by abnormal production of extracellular matrix protein,thickening of peritoneal interstitial connective tissue,damage of peritoneal mesothelial cells and neovascularization. Currently there is no effective therapy. Traditional Chinese medicine offers unique advantages in the prevention and treatment of peritoneal fibrosis. With an excellent clinical efficacy,it has demonstrated some promising results of experimental research. This review summarized the latest advances of animal models,single/compound herbal medications and acupuncture in the treatment of PD. It provided basic theoretical guidance for clinical application of Chinese medicine in the prevention and treatment of PD-related peritoneal fibrosis.

       

    /

    返回文章
    返回